Research location
New Brunswick
New Jersey, United States
Advertisement
Research activity in New Brunswick
New Jersey, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 708 trials and 784 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in New Brunswick
708 linked trials · page 2 of 15A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation
RECRUITING
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerNCT05946213 · 2023-12-14 · 1 site observation
RECRUITING
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerNCT06058377 · 2023-11-27 · 1 site observation
RECRUITING
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT05696626 · 2023-10-31 · 1 site observation
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25NCT05879926 · 2023-10-18 · 1 site observation
RECRUITING
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsNCT06026410 · 2023-10-18 · 1 site observation
RECRUITING
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaNCT06057935 · 2023-09-21 · 1 site observation
RECRUITING
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationNCT05877599 · 2023-07-12 · 1 site observation
RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerNCT05624996 · 2023-07-12 · 1 site observation
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabNCT05812807 · 2023-06-14 · 1 site observation
RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNCT05564377 · 2023-04-07 · 1 site observation
RECRUITING
TELESCOPE- TELEhealth Shared Decision-making COachingNCT05491213 · 2023-02-14 · 1 site observation
RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)NCT05633654 · 2022-12-12 · 1 site observation
RECRUITING
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerNCT05498428 · 2022-11-11 · 1 site observation
RECRUITING
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerNCT05483491 · 2022-09-26 · 2 site observations
RECRUITING
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedNCT05559164 · 2022-09-19 · 2 site observations
RECRUITING
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerNCT05467891 · 2022-09-13 · 1 site observation
RECRUITING
IVIG vs SCIG in CIDPNCT05584631 · 2022-09-11 · 1 site observation
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18 · 1 site observation
RECRUITING
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaNCT05433142 · 2022-06-13 · 1 site observation
RECRUITING
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionNCT05245500 · 2022-06-09 · 1 site observation
RECRUITING
ATATcH Alternating Treatment Plans for Advanced CancerNCT05358548 · 2022-04-28 · 2 site observations
RECRUITING
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaNCT05235165 · 2022-04-01 · 2 site observations
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerNCT05216432 · 2021-12-08 · 1 site observation
RECRUITING
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerNCT05125016 · 2021-11-30 · 1 site observation
RECRUITING
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsNCT04913285 · 2021-08-04 · 1 site observation
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerNCT04181060 · 2020-12-28 · 1 site observation
RECRUITING
Parkinson's Foundation PD GENEration Genetic RegistryNCT04994015 · 2020-12-20 · 1 site observation
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingNCT04423211 · 2020-10-08 · 1 site observation
RECRUITING
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmNCT04317534 · 2020-05-05 · 1 site observation
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerNCT03424005 · 2018-03-30 · 1 site observation
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774 · 2018-01-01 · 1 site observation
RECRUITING
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection FractionNCT02901184 · 2017-11-23 · 1 site observation
RECRUITING
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsNCT03093116 · 2017-03-07 · 1 site observation
RECRUITING
Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryNCT02418442 · 2015-07-01 · 1 site observation
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerNCT01042379 · 2010-03-01 · 1 site observation
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)NCT07115199 · 2026-11-01 · 1 site observation
NOT_YET_RECRUITING
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)NCT07680790 · 2026-09-30 · 1 site observation
NOT_YET_RECRUITING
Continued Access to the Endogenex System for Participants in the ReCET Pivotal StudyNCT07197788 · 2026-09-01 · 1 site observation
ENROLLING_BY_INVITATION
SHORTened Duration of TAMoxifenNCT07806630 · 2026-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryNCT06965504 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Expanding Genetic Access for Prostate Cancer SurvivorsNCT07618520 · 2026-08-01 · 1 site observation
NOT_YET_RECRUITING
Pilot Testing a Web-based Prototype of a Lung Cancer Screening Digital Health ToolNCT07716527 · 2026-06-01 · 1 site observation
ENROLLING_BY_INVITATION
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer SurvivorsNCT06834204 · 2026-04-24 · 1 site observation
ENROLLING_BY_INVITATION
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple SclerosisNCT07008378 · 2025-10-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Pilot Trial of Preop Partial Radiation in Breast Cancer PatientsNCT07178665 · 2025-09-02 · 1 site observation
SUSPENDED
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)NCT06736431 · 2025-07-15 · 1 site observation
COMPLETED
Trial of ctDNA of Guidance to Determine PostOperative Radiation TherapyNCT06979661 · 2025-06-01 · 1 site observation
NOT_YET_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.